Category Archives: Chantix

Featured Stories

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Image Source: saidaonline.com

Sleep Aids Can Increase Alzheimer’s Risk

A new study has found that over-the-counter sleeping aids and anti-allergy medicines can increase the risk of Alzheimer’s disease.

Read More

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Having already spent around $3 billion on its DePuy Orthopaedics ASR hip implant recall, Johnson & Johnson is facing another potential debacle involving a metal-on-metal version of its Pinnacle Hip Replacement System. According to a report from Reuters, Johnson & Johnson and its DePuy unit already face some 1,600 metal-on-metal ...

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Inc.’s published studies for its Infuse bone graft product may have downplayed serious side effects, according to an analysis published last year in The Spine Journal. The study, which drew on U.S. Food & Drug Administration (FDA) documents and other data sources, suggests that up to half of ...

Read More

Scientist Calls for Federal Regulations for Fracking Pollution

Hydraulic fracturing (fracking) drilling should be governed by federal regulations because its pollution has no awareness of state boundaries.

Read More

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

Post -Tonsillectomy Morphine Life-Threatening in Children

Post -Tonsillectomy Morphine can be Life-Threatening in Children, Study Finds

A new study published in Pediatrics suggests that morphine can result in life-threatening respiratory problems when given to children after a tonsillectomy.

Read More

FDA Scrutinizes Pfizer Study Evaluating Chantix Suicide Risks

FDA Scrutinizes Pfizer Study Detailing Chantix Suicide Risks

The U.S. Food and Drug Administration (FDA) is questioning whether or not Pfizer’s study of neuropsychiatric effects of Chantix, the smoking cessation drug, accurately reflects the risks. Pfizer conducted the clinical trial upon request from the FDA, following a high … Continue reading

Posted in Chantix, Pharmaceuticals | Tagged , , , , , , , |

Expert Witness in Chantix Case Seeks Pfizer Documents

An expert witness in the multidistrict litigation over Chantix (varenicline), a smoking cessation drug, has moved to unseal court records in advance of a Food and Drug Administration (FDA) meeting to consider whether the drug should carry a warning about … Continue reading

Posted in Chantix, Pharmaceuticals |

FDA to Convene Panel on Smoking Cessation Drug, Chantix, Over Psychiatric, Behavioral Side Effect Risks

The U.S. Food and Drug Administration (FDA) announced that it plans to review Chantix, the smoking cessation drug, to determine if its quit smoking benefits exceed its psychiatric and behavioral risks, Approved in 2006, Chantix received the U.S. Food and … Continue reading

Posted in Chantix, Pharmaceuticals |

Motion denied to delay Chantix trial

The first trial alleging the stop-smoking drug Chantix causes serious and some life-threatening side effects will go forward as scheduled after a federal court judge denied a request by the drug’s maker to delay it in light of a new … Continue reading

Posted in Chantix, Health Concerns, Pharmaceuticals | Tagged |

BPA Side Effects May Be Long Lasting

A recent study suggests that the side effects of BPA may be long lasting. BPA, or bisphonel A, a controversial plastics chemical, has been linked to a growing and broad array of adverse health effects. In this study, the effects … Continue reading

Posted in Chantix, Legal News, Radiation Exposure Environmental Contamination |

U. Of Penn Researchers Testing Chantix Despite Risks

Despite its known risks, University of Pennsylvania researchers plan on testing the smoking cessation medication, Chantix (varenicline). The U.S. Food & Drug Administration (FDA) approved Chantix in 2006. Chantix blocks nicotine by targeting the brain’s nicotine receptors; however, about a … Continue reading

Posted in Chantix, Health Concerns, Pharmaceuticals |

Study Finds Chantix Linked to Suicidal Behavior, Depression More Frequently than Other Stop-Smoking Treatments

A team of researchers is calling on the U.S. Food & Drug Administration (FDA) to beef up warnings for < "http://www.yourlawyer.com/topics/overview/chantix_side_effects">Chantix (varenicline), after their study found the drug’s psychological side effects make it unsuitable for first-line use as a smoking-cessation … Continue reading

Posted in Chantix, Pharmaceuticals |

FDA Modifies Chantix Label for Heart, COPD Patients

The < "http://www.yourlawyer.com/topics/overview/chantix_side_effects">Chantix label has been updated with new information regarding the safety and efficacy of the smoking cessation medication, according to an announcement from the U.S. Food & Drug Administration (FDA). The modifications to the Chantix label apply to … Continue reading

Posted in Chantix, Pharmaceuticals |

Chantix Study Sees Significant Increase in Heart Risks

People taking < "http://www.yourlawyer.com/topics/overview/chantix_side_effects">Chantix (varenicline), Pfizer Inc.’s controversial stop-smoking drug, face a much higher risk of heart attacks, strokes and other serious cardiovascular events, according to a new study from researchers at Johns Hopkins University and Wake Forest Baptist Medical … Continue reading

Posted in Chantix, Pharmaceuticals |

Health Canada Reviewing Champix for Heart Side Effects

Health Canada is reviewing the smoking cessation drug Champix (sold as < "http://www.yourlawyer.com/topics/overview/chantix_side_effects">Chantix is the U.S.) for a possible link to heart problems. The Health Canada announcement follows last week’s notification by the U.S. Food & Drug Administration (FDA) that … Continue reading

Posted in Chantix, Pharmaceuticals |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.